IRB Advisor – July 1, 2005
July 1, 2005
View Issues
-
Overcoming barriers to Hispanic participation in clinical trials
In the past few years, Hispanics have become the largest minority group in the United States, numbering nearly 41.3 million in the most recent U.S. Census estimates. -
Steps IRBs can take to increase Hispanic participation
What can IRBs do to help reach out to the Hispanic population in their own communities? -
IRB costs are greater than previous estimates
The cost of operating institutional review boards is higher than previous estimates had indicated, according to a survey published recently in the New England Journal of Medicine. -
Fear about side effects hinder trial participation
Physicians discussing clinical trials with their patients may not realize the importance of patients fears about side effects in making a decision about whether to participate. -
Should administrators be voting members?
Particularly at smaller institutions, IRB administrators who also serve as voting members can offer many benefits. They attend and coordinate all meetings, so counting them as members helps the board achieve quorum. -
News Briefs
Only 75% of patients that begin clinical trials for drugs fully complete, according to a recent study by Cutting Edge Information in Research Triangle Park, NC, noting several reasons for this low completion rate.